Cognate BioServices, a cellular therapies manufacturer, would build offices, distribution space and clean-room manufacturing cells at its 4600 E. Shelby Drive headquarters and two nearby locations.

After a brief discussion, the Economic Development and Growth Engine for Memphis and Shelby County board approved Cognate BioServices’ application requesting a payment in lieu of taxes incentive ...

BALTIMORE & MEMPHIS, Tenn.–(BUSINESS WIRE)–Cognate BioServices, a leading contract development and manufacturing organization (“CDMO”) in the global cellular therapies industry ...

With the demand for cell and gene therapies mounting, CDMO Cognate BioServices is looking to swiftly expand its U.S. headquarters with two new facilities—and it's not stopping there. Its dedicat ...

Just a few weeks after Cognate BioServices moved to beef up its cell and gene therapy manufacturing, the company has attracted a buyer eager to tap that expertise. Charles River Laboratories ...

To assure that these shares will not be a factor in the market for an extended period of time, the Company and Cognate also entered into a lock-up agreement pursuant to which Cognate agreed to an ...

Figure 1: Generation of CD8 + T cell immunity to HSV-1 after subcutaneous infection requires cognate CD4 + T cell help. Figure 2: Generation of CD8 + T cell immunity to HSV-1 after intravenous ...